The IASLC Lung Cancer Database Summary of Cases Contributed to Project Total cases submitted 100,869 Excluded from analyses Excluded from analyses19,854.

Slides:

Advertisements

Similar presentations

Small Cell Lung Cancer Clinical T-Stage, N0-N3 M0 SCLC From: Shepherd FA, Crowley J, Van Houtte P et al. The IASLC lung cancer staging project: proposals.

Advertisements

Jaime Palomino, MD Pulmonary, Critical Care Medicine Tulane University.

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

Pier Luigi Filosso, MD University of Torino, Department of Thoracic Surgery The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine.

AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #3 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.

AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #1 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.

SWISS TUMOR BOARD Lung Cancer March 26, 2009 Novotel Bern Prof. Dr. Mahmut Ozsahin Lausanne University Medical Center (CHUV), Lausanne.

강 창 현 서울대학교병원 흉부외과 서울대학교 의과대학. Staging Communication Evaluation TreatmentPrognosis Research.

Multimodality therapy for locally advanced thymomas: a cohort study of prognostic factors from a European multicentric database Dr. GIOVANNI LEUZZI Department.

Malignant Pleural Effusion (M.P.E.)

Postoperative Radiotherapy for Patients with Stage II or III Nonsmall Cell Lung Cancer treated with Sublobar Resections: A SEER Registry Analysis Scott.

First author: Roman Adina Co-author: Andone Sebastian

Clinical variables, pathological factors, and molecular markers for enhanced soft tissue sarcoma prognostication G. Lahat, B. Wang, D. Tuvin, DA. Anaya,

Development of Lung Cancer Staging Steven M. Keller, M.D. Director Thoracic Surgery, Weiler Hospital Professor of Cardiothoracic Surgery Albert Einstein.

“Validation” of the Proposed IASLC/ITMIG Staging Revisions of Thymic Carcinomas Using Data from 287 Patients Yang Zhao; Heng Zhao Division of Thoracic.

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl,

Evidence Based Approach 5-Year Survival Rate for Breast Cancer Stage IV is 14% 2 to 5 percent become long-term survivors, possibly cured of their disease.

Joan Schiller, MD Professor of Medicine Chief, Division of Hematology/Oncology University of Texas Southwestern Medical Center Deputy Director Simmons.

Non-small cell lung cancer Lancet 2011;378: Peter Goldstraw, David Ball, James R Jett, Thierry Le Chevalier, Eric Lim, Andrew G Nicholson, Frances.

Brain imaging prior to lung cancer resection

TNM Classification of Malignant Tumours - 8th edition Changes between the 7th and 8th editions December 2016 “We unite the cancer community to reduce.

The IASLC Lung Cancer Staging Project The 8th Edition

Fig. 3 Overall and disease-free survival of single-zone metastasis group according to the number of stations involved. No significant differences were.

Jacob Sands, MD Dana-Farber Cancer Institute October 25, 2017

Prognosis of younger patients in non-small cell lung cancer

Clinical Outcome of Chemoradiation Therapy in Patients with Limited-Disease Small Cell Lung Cancer with Ipsilateral Pleural Effusion Seiji Niho, MD,

The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification.

Proposed Changes to the 7th Edition

The IASLC Lung Cancer Database

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Nat. Rev. Clin. Oncol. doi: /nrclinonc

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer.

The Stage Classification of Lung Cancer

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification.

Shidan Wang, BS, Lin Yang, MD, Bo Ci, BS, Matthew Maclean, BS, David E

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the T component for the Forthcoming (8th) Edition of the TNM Classification of.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming.

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients Elizabeth A. David, MD, Stina W. Andersen, PhD,

The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer Ramón Rami-Porta, MD, FETCS,

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Brian N. Arnold, MD, Daniel C. Thomas, MD, MPH, Joshua E

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Peter Goldstraw, MB, FRCS, John J. Crowley, PhD

Nael Martini, MDa, Manjit S. Bains, MDa, Michael E

The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming.

The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition Sai-Hong.

Leora Horn, MD, MSc, FRCPC, Alan B. Sandler, MD, Joe B

The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification.

Subcategorization of Lung Cancer Based on Tumor Size and Degree of Visceral Pleural Invasion⁎ Noriaki Sakakura, MD, Shoichi Mori, MD, Katsuhiro Okuda,

Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002 Noriyoshi Sawabata, MD,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Valerie W Rusch, MD, Ennapadam S Venkatraman, PhD

Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis Alessandro Marra, MD, PhD, Ludger Hillejan, MD,

Results of surgical treatment of non–small cell lung cancer: validation of the new postoperative pathologic tnm classification Jacek Jassem, MDa, Jan.

The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for.

The International Association for the Study of Lung Cancer Lung Cancer Staging Project Hisao Asamura, MD, Kari Chansky, MS, John Crowley, PhD, Peter.

The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho- Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM.

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Frequency and Prognostic Significance of Preoperatively Detected Enlarged Regional Lymph Nodes in Patients with Pathological Stage I Non-small Cell Lung.

Validation of the Proposed International Association for the Study of Lung Cancer Non- small Cell Lung Cancer Staging System Revisions for Advanced Bronchioloalveolar.

Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section.

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database Valerie W. Rusch, MD, Dorothy Giroux, Catherine.

Should the 7th Edition of the Lung Cancer Stage Classification System Change Treatment Algorithms in Non-small Cell Lung Cancer? Daniel J. Boffa, MD,

NSCLC: Staging and TNM classification

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

The IASLC Lung Cancer Staging Project

Survival of Patients With Unsuspected pN2 Non-Small Cell Lung Cancer After an Accurate Preoperative Mediastinal Staging Carme Obiols, MD, Sergi Call,

Presentation transcript:

The IASLC Lung Cancer Database Summary of Cases Contributed to Project Total cases submitted 100,869 Excluded from analyses Excluded from analyses19,854 Outside of time frame Outside of time frame5,443 Incomplete survival data Incomplete survival data1,505 Unknown histology Unknown histology2,468 Incomplete stage information Incomplete stage information7,720 Recurrent cases and other exclusions Recurrent cases and other exclusions1,603 Carcinoids, sarcomas and other histologies Carcinoids, sarcomas and other histologies1,115 Included in analyses 81,015 Small Cell Lung Cancer (and mixed SCLC/NSCLC)Small Cell Lung Cancer (and mixed SCLC/NSCLC)13,290 Non-Small Cell Lung CancerNon-Small Cell Lung Cancer67,725 Updated from: Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International staging project on lung cancer. J Thorac Oncol 2006; 1:

The IASLC Lung Cancer Database Treatment Modalities 81,495 Cases Surgery36% Chemotherapy21%RT11% Surgery + Chemo 4% Surgery + RT 4% Chemo 12% Surgery + Chemo + RT 3% No treatment details or best supportive care: 10% From: Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International staging project on lung cancer. J Thorac Oncol 2006; 1:

The IASLC Lung Cancer Database Types of Contributing Groups 81,495 Cases

The IASLC Lung Cancer Database Stage Distribution, Non-small Cell Lung Cancer 67,725 Cases with Clinical Stage, Pathological Stage, or Both

The IASLC Lung Cancer Database Clinical Stage Distribution by Continent, Non-small Cell Lung Cancer 53,646 Cases 58% 7%21%14% Percent of total cases contributed with clinical stage From: Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International staging project on lung cancer. J Thorac Oncol 2006; 1:

The IASLC Lung Cancer Database Pathological Stage Distribution by Continent, Non-small Cell Lung Cancer 33,933 Cases Percent of total cases contributed with pathologic stage 51%7%13%28%

The IASLC Lung Cancer Database Stage Distribution by Continent, Small Cell Lung Cancer 13,290 Cases (58%) (6%) (34%)(2%) Percent of total small cell cases contributed From: Goldstraw P, Crowley JJ. The International Association for the Study of Lung Cancer International staging project on lung cancer. J Thorac Oncol 2006; 1:

T-Descriptors – Size of Primary Tumor “Best Split” for Tumor Size, pT1 Cases From: Rami-Porta R, Ball D, Crowley J et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

T-Descriptors – Size of Primary Tumor “Best Split” for Tumor Size, pT2 Cases 7.3 cm From: Rami-Porta R, Ball D, Crowley J et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

Size of Primary Tumor, pT1-3, N0 NSCLC T-Descriptors – Size of Primary Tumor From: Rami-Porta R, Ball D, Crowley J et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

Size of Primary Tumor, cT1-3, N0 NSCLC T-Descriptors – Size of Primary Tumor From: Rami-Porta R, Ball D, Crowley J et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

T-Descriptors - Validation Size of Primary Tumor T1-3 N0 NSCLC United States National Cancer Institute SEER Registries From: Groome PA, Bolejack V, Crowley JJ et al. The IASLC lung cancer project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:

Pathological T3/T4 – M1 NSCLC T-Descriptors – Additional Nodules and Pleural Dissemination From: Rami-Porta R, Ball D, Crowley J et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

T-Descriptors – Additional Nodules and Pleural Dissemination Clinical T3/T4 – M1 NSCLC From: Rami-Porta R, Ball D, Crowley J et al. The IASLC lung cancer staging project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

T-Descriptors - Validation Additional Nodules and Pleural Dissemination, T3/4-M1 NSCLC United States National Cancer Institute SEER Registries From: Groome PA, Bolejack V, Crowley JJ et al. The IASLC lung cancer project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:

N-Descriptors Clinical N-stage, cN0-cN3 From: Rusch VW, Crowley J, Giroux DJ et al. The IASLC lung cancer project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

N-Descriptors Surgically Managed Patients From: Rusch VW, Crowley J, Giroux DJ et al. The IASLC lung cancer project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

N-Descriptors - Validation N-Stage N0-N3, M0 NSCLC United States National Cancer Institute SEER Registries From: Groome PA, Bolejack V, Crowley JJ et al. The IASLC lung cancer project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:

N-Descriptors: Nodal Zones Shown in: Rusch VW, Crowley J, Giroux DJ et al. The IASLC lung cancer project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2: Copyright Memorial Sloan-Kettering Cancer Center. Used with permission.

N-Descriptors N-Status and Number of Involved N-Zones From: Rusch VW, Crowley J, Giroux DJ et al. The IASLC lung cancer project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:

M-Descriptors Clinically Staged T4 and M1 Descriptors From: Postmus PE, Brambilla E, Chansky K et al. The IASLC lung cancer project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2:

M-Descriptors Best* Stage T4 and M1 Descriptors *Best Stage = Path stage if available, otherwise clinical From: Postmus PE, Brambilla E, Chansky K et al. The IASLC lung cancer project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2:

M-Descriptors - Validation T4 and M1 Descriptors United States National Cancer Institute SEER Registries From: Postmus PE, Brambilla E, Chansky K et al. The IASLC lung cancer project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007; 2:

TNM Stage Category RPA Output for Analysis of TNM Stage Groupings From: Goldstraw P, Crowley J, Chansky K et al. The IASLC lung cancer project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:

TNM Stage Category Clinical TNM Stage v. 6 and Proposed v. 7 cTNM 6 th Edition cTNM 7 th Edition From: Goldstraw P, Crowley J, Chansky K et al. The IASLC lung cancer project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:

TNM Stage Category Pathological Stage v. 6 and Proposed v. 7 pTNM 6 th Edition pTNM 7 th Edition From: Goldstraw P, Crowley J, Chansky K et al. The IASLC lung cancer project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2:

TNM Stage Category - Validation TNM Stage v. 6 and Proposed v. 7 United States National Cancer Institute SEER Registries TNM 6 th Edition TNM 7 th Edition From: Groome PA, Bolejack V, Crowley JJ et al. The IASLC lung cancer project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007; 2: